¹⁸F-MFBG PET/CT多参数模型鉴别神经母细胞瘤与节细胞神经母细胞瘤的诊断效能初步研究
本研究回顾性纳入42例经组织学确诊的儿童患者(NB 23例,GNB 19例),构建整合¹⁸F-MFBG PET/CT定量参数与临床因素的多参数诊断模型,用于无创鉴别NB与GNB。联合模型(SUVmax+年龄+骨转移)AUC为0.856(95%CI:0.737-0.975),较仅SUVmax模型和临床因素模型显示判别能力改善趋势,IDI分析支持联合模型的增量价值。结论提示该模型具有初步诊断潜力,尚需更大规模多中心外部验证。
要点
- ¹⁸F-MFBG PET/CT的SUVmax、SUVmean、TBRmean、TBRmax、AUC-CSH和TL-hNET在NB与GNB间差异显著(P<0.05)。
- 多变量Firth模型中SUVmax(OR=8.665,P=0.029)和年龄(OR=0.676,P=0.043)与NB独立相关。
- 联合模型(SUVmax+年龄+骨转移)AUC为0.856(95%CI:0.737-0.975),IDI分析支持其增量价值。
核心结论
- 整合¹⁸F-MFBG PET/CT成像参数与临床因素的多参数模型为鉴别NB与GNB提供了有前景的初步诊断假设,尚待更大规模多中心队列的严格外部验证。
研究设计与样本
- 回顾性研究,纳入42例经组织学确诊的儿童患者(NB 23例,GNB 19例),均在治疗前接受¹⁸F-MFBG PET/CT检查。
- 提取定量成像参数和临床数据,采用Spearman秩相关系数评估相关性,方差膨胀因子(VIF)评估多重共线性。
- 采用单变量和多变量Firth逻辑回归分析筛选独立预测因子,通过ROC分析、DeLong检验、bootstrap验证、NRI和IDI评估模型判别效能。
主要发现
- SUVmax、SUVmean、TBRmean、TBRmax、AUC-CSH和TL-hNET在NB与GNB之间差异显著(P<0.05)。
- 成像参数间存在严重多重共线性(VIF>10),选择SUVmax进入多变量建模,与年龄、骨转移和11q23缺失作为最强临床预测因子。
- 多变量Firth模型中SUVmax(OR=8.665,P=0.029)和年龄(OR=0.676,P=0.043)与NB独立相关,骨转移显示与NB独立关联趋势(OR=11.753,P=0.050)。
- 联合模型AUC为0.856(95%CI:0.737-0.975),较SUVmax-only模型(AUC=0.810,95%CI:0.668-0.952)和临床因素模型(AUC=0.787,95%CI:0.659-0.916)显示判别能力改善趋势。
- Bootstrap验证(2000次重采样)和IDI分析支持联合模型的增量价值(联合vs SUVmax-only:IDI=0.122,P=0.014;联合vs临床:IDI=0.083,P=0.045)。
关键数值与推荐
- 联合模型(SUVmax+年龄+骨转移)鉴别NB与GNB的AUC为0.856(95%CI:0.737-0.975)。
- SUVmax-only模型AUC为0.810(95%CI:0.668-0.952),临床因素模型(年龄+骨转移)AUC为0.787(95%CI:0.659-0.916)。
- 联合vs SUVmax-only的IDI=0.122(P=0.014),联合vs临床因素的IDI=0.083(P=0.045)。
临床怎么用
- 在儿童神经母细胞瘤与节细胞神经母细胞瘤的鉴别中,可考虑综合¹⁸F-MFBG PET/CT的SUVmax及年龄、骨转移等临床因素进行无创评估。
- 该模型为初步研究结果,临床应用中需结合组织病理学确诊,不可替代病理诊断。
局限性
- 本研究为初步研究,样本量较小(42例),需在更大规模多中心队列中进行严格外部验证。
- 成像参数间存在严重多重共线性(VIF>10),建模时仅选择SUVmax代表成像参数。
- 骨转移与NB的独立关联仅接近统计学显著性(P=0.050)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop and preliminarily validate a multiparametric diagnostic model integrating ¹⁸F-meta-fluorobenzylguanidine (¹⁸F-MFBG) PET/CT imaging parameters with clinical factors for noninvasive differentiation of neuroblastoma (NB) from ganglioneuroblastoma (GNB) in pediatric patients. METHODS: This retrospective study enrolled 42 pediatric patients with histologically confirmed NB (n = 23) or GNB (n = 19) who underwent ¹⁸F-MFBG PET/CT prior to treatment. Quantitative imaging parameters and clinical data were extracted. Correlations were assessed using Spearman's rank correlation coefficient. Multicollinearity among predictors was evaluated using variance inflation factors (VIF). Univariate and multivariable Firth logistic regression analyses were performed to identify independent predictors. The discriminative performance of the model was evaluated via receiver operating characteristic (ROC) analysis, the DeLong test, bootstrap validation, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). RESULTS: SUVmax, SUVmean, TBRmean, TBRmax, AUC-CSH and TL-hNET differed significantly between NB and GNB(P < 0.05). Severe multicollinearity (VIF > 10) was observed among imaging parameters, SUVmax was selected for multivariable modeling, along with age, bone metastasis and 11q23 deletion as the strongest clinical predictors. In the multivariable Firth model, SUVmax (OR = 8.665; P = 0.029) and age (OR = 0.676; P = 0.043) remained independently associated with NB. Bone metastasis showed a trend toward independent association with NB (OR = 11.753; P = 0.050), with the association approaching statistical significance. Three diagnostic models were constructed and compared: (1) imaging-only model (SUVmax); (2) clinical-factor model (age + bone metastasis); and (3) integrated model (SUVmax + age + bone metastasis). The combined model achieved an AUC of 0.856(95%CI:0.737-0.975), showing a trend toward improved discrimination compared with both the SUVmax-only model (AUC = 0.810, 95%CI:0.668-0.952) and the clinical-factor model (AUC = 0.787, 95%CI:0.659-0.916). Bootstrap validation (2000 resamples) and IDI analysis provided supportive evidence of incremental value of the integrated model (Combined vs. SUVmax-only: IDI = 0.122, P = 0.014; Combined vs. clinical: IDI = 0.083, P = 0.045). CONCLUSION: The multiparametric model integrating ¹⁸F-MFBG PET/CT imaging parameters with clinical factors generated a promising preliminary hypothesis for diagnostic performance for differentiating NB from GNB, pending rigorous external validation in larger, multicenter cohorts.
引用
- Wang X, Zhang K, Kan Y, et al. Diagnostic performance of multiparametric model integrating ¹⁸F-MFBG PET/CT imaging parameters and clinical factors for differentiating neuroblastoma from ganglioneuroblastoma: a preliminary study. Eur J Nucl Med Mol Imaging. 2026. PMID: 42820950. doi:10.1007/s00259-026-08185-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。